Searched for
ASTRAZENECA PHARMA TECH OUTLOOK
K-Drama on Tech Street: AI rout hits global marketsTechnology stocks experienced a significant downturn, pulling major indices lower as a sharp selloff in Korean chipmakers raised concerns a...- Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...
- UN chief calls on AI firms to come clean on environmental costsThe rapid development of data centres globally to fuel the AI revolution has drawn scrutiny from environmental groups for their high energy...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Sensex trades on choppy note, Nifty below 24,100 as IT stocks drag benchmarks lowerIndian stock markets saw a subdued trading session on Tuesday, with the Sensex and Nifty experiencing minor dips, primarily due to losses i...
- Sensex rises 291 points, Nifty closes above 24,100; Tech Mahindra, Sun Pharma among top gainersIndian stock markets saw a positive start on Monday, with Sensex and Nifty inching up after Friday's dip. Tech Mahindra led the gains, whil...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Infosys, HCL Tech, Coforge, other IT stocks rise up to 3% a day after a massive crash. What lies ahead?IT stocks rebounded after a sharp sell-off triggered by Accenture’s guidance cut, with gains led by Coforge and Tech Mahindra. Analysts see...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Will Sensex, Nifty bounce back on Monday? Iran peace deal risks among 5 factors to drive D-St this weekIndian stock markets experienced a sharp decline on Friday, breaking a five-day winning streak. Key factors influencing Dalal Street next w...
- Why did market fall today? Sensex slumps 600 points, Nifty closes below 24,050. IT selloff among 5 key triggersIndian equities experienced a sharp decline on Friday, snapping a five-day winning streak as IT stocks faced heavy selling pressure. Weak g...
- Nifty IT crashes 6% to 3-year low as Infosys, HCL Tech, other IT stocks crash up to 9%. Time to buy the dip?The Nifty IT index slumped over 6% to a three-year low after Accenture’s guidance cut triggered a sharp sell-off in Infosys, TCS, HCLTech a...
- TCS, Infosys, Wipro, other IT stocks crash up to 8% as Accenture lowers FY26 guidanceIndian IT stocks, including TCS and Infosys, tumbled up to 8% after Accenture lowered its annual revenue growth forecast, signaling continu...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities ended higher for a fifth straight session, recovering early losses despite hawkish Federal Reserve comments. Banking stocks...
- Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...
- Global Markets| European shares flat as investors await Iran deal details, Fed policy; BMW slidesEuropean markets held firm today, with investors keenly awaiting developments regarding potential peace talks between the U.S. and Iran, al...
- HCL Tech shares jump 3% after buying stake in Sarvam AI for Rs 1,427 croreHCL Tech share price gained 3% after i invested $150 million in Sarvam AI, India's largest AI startup, acquiring a 10.46% stake. This strat...
- Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
Load More
